文献速递乳腺癌放疗姑息放疗与转移瘤

乳腺癌区域淋巴结放疗后症状负担与早期淋巴管异常的关联

Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer.
PubMed 文献 · Pract Radiat Oncol · 2023-10-31

本研究前瞻性纳入60例接受腋窝清扫与区域淋巴结放疗的乳腺癌患者,在基线、术后及放疗后6、12、18个月行体积测量、近红外荧光淋巴成像(NIRF-LI)和患者报告淋巴水肿结局(PRLO)调查。结果显示真皮回流与临床淋巴水肿从基线至18个月分别由10%升至85%、由0%升至40%,真皮回流与LSIDS部分亚量表及QuickDASH评分相关。

要点

  • 真皮回流与临床淋巴水肿从基线至18个月分别由10%升至85%、由0%升至40%。
  • 调整模型中,软组织感觉、神经感觉和功能LSIDS亚量表评分与真皮回流存在关联(均P<.05)。
  • 真皮回流与淋巴水肿均与QuickDASH评分相关(P<.05)。

核心结论

  • 在这一高危队列中,早期淋巴水肿体征非常普遍,且症状负担较基线增加。
  • 真皮回流与患者报告淋巴水肿结局指标相关,提示NIRF-LI或可用于识别区域淋巴结放疗后适合早期干预试验的患者。

研究设计与样本

  • 前瞻性研究,纳入计划接受腋窝清扫和区域淋巴结放疗的乳腺癌患者,共60例完成至少2组测量和调查并纳入分析。
  • 在基线、术后及放疗后6、12、18个月进行体积测量、近红外荧光淋巴成像(NIRF-LI)和患者报告淋巴水肿结局调查(LSIDS和QuickDASH)。
  • 临床淋巴水肿定义为手臂体积较基线增加≥5%;采用方差分析评估时间趋势,采用线性混合效应模型评估调查应答与真皮回流及淋巴水肿的关联。

主要发现

  • 54%的患者为cT3-T4期疾病,53%为cN3期疾病,75%的患者体重指数>25。
  • 真皮回流从基线的10%升至18个月时的85%,临床淋巴水肿从基线的0%升至18个月时的40%。
  • 在调整模型中,软组织感觉、神经感觉和功能LSIDS亚量表评分与真皮回流存在关联(均P<.05)。
  • 真皮回流和淋巴水肿均与QuickDASH评分相关(P<.05)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Dermal backflow visualized on near-infrared fluorescence lymphatic imaging (NIRF-LI) signals preclinical lymphedema that precedes the development of volumetrically defined lymphedema. We sought to evaluate whether dermal backflow correlates with patient-reported lymphedema outcomes (PRLO) surveys in breast cancer patients treated with regional nodal irradiation (RNI). METHODS AND MATERIALS: Patients with breast cancer planned for axillary dissection and RNI prospectively underwent perometry, NIRF-LI, and PRLOs (the Lymphedema Symptom Intensity and Distress Survey [LSIDS] and QuickDASH) at baseline, after surgery, and at 6, 12, and 18 months after radiation. Clinical lymphedema was defined as an arm volume increase ≥5% over baseline. Trends over time were assessed using analysis of variance testing. The association between survey responses and both dermal backflow and lymphedema was assessed using a linear mixed-effects model. RESULTS: Sixty participants completed at least 2 sets of measurements and surveys and were eligible for analysis. Fifty-four percent of patients had cT3-T4 disease, 53% cN3 disease, and 75% had a body mass index >25. Dermal backflow and clinical lymphedema increased from 10% to 85% and from 0% to 40%, respectively, from baseline to 18 months. In the adjusted model, soft tissue sensation, neurologic sensation, and functional LSIDS subscale scores were associated with presence of dermal backflow (all P < .05). Both dermal backflow and lymphedema were associated with QuickDASH score (P < .05). CONCLUSIONS: In this high-risk cohort, we found highly prevalent early signs of lymphedema, with increased symptom burden from baseline. Presence of dermal backflow correlated with PRLO measures, highlighting a potential NIRF-LI use to identify patients for early intervention trials after RNI.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Yoder AK, Xu T, Youssef P, et al. Association Between Symptom Burden and Early Lymphatic Abnormalities After Regional Nodal Irradiation for Breast Cancer. Pract Radiat Oncol. 2023. PMID: 37914083. doi:10.1016/j.prro.2023.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。